These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Brief Report: Challenging Behaviors in Toddlers and Preschoolers with Angelman, Prader-Willi, and Williams Syndromes. Neo WS, Tonnsen BL. J Autism Dev Disord; 2019 Apr; 49(4):1717-1726. PubMed ID: 30542941 [Abstract] [Full Text] [Related]
3. Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome. Kayadjanian N, Vrana-Diaz C, Bohonowych J, Strong TV, Morin J, Potvin D, Schwartz L. PLoS One; 2021 Apr; 16(3):e0248739. PubMed ID: 33765021 [Abstract] [Full Text] [Related]
4. Sleep phenotypes in infants and toddlers with neurogenetic syndromes. Abel EA, Tonnsen BL. Sleep Med; 2017 Oct; 38():130-134. PubMed ID: 29031747 [Abstract] [Full Text] [Related]
5. Analysis of Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome. Matesevac L, Vrana-Diaz CJ, Bohonowych JE, Schwartz L, Strong TV. Sci Rep; 2023 Nov 23; 13(1):20573. PubMed ID: 37996659 [Abstract] [Full Text] [Related]
6. Are Angelman and Prader-Willi syndromes more similar than we thought? Food-related behavior problems in Angelman, Cornelia de Lange, fragile X, Prader-Willi and 1p36 deletion syndromes. Welham A, Lau J, Moss J, Cullen J, Higgs S, Warren G, Wilde L, Marr A, Cook F, Oliver C. Am J Med Genet A; 2015 Mar 23; 167A(3):572-8. PubMed ID: 25691410 [Abstract] [Full Text] [Related]
10. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia. Kweh FA, Miller JL, Sulsona CR, Wasserfall C, Atkinson M, Shuster JJ, Goldstone AP, Driscoll DJ. Am J Med Genet A; 2015 Jan 23; 167A(1):69-79. PubMed ID: 25355237 [Abstract] [Full Text] [Related]
11. TPH2 G/T polymorphism is associated with hyperphagia, IQ, and internalizing problems in Prader-Willi syndrome. Dykens EM, Roof E, Bittel D, Butler MG. J Child Psychol Psychiatry; 2011 May 23; 52(5):580-7. PubMed ID: 21418060 [Abstract] [Full Text] [Related]
12. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome. Wieting J, Jahn K, Buchholz V, Lichtinghagen R, Deest-Gaubatz S, Bleich S, Eberlein CK, Deest M, Frieling H. Psychoneuroendocrinology; 2022 Sep 23; 143():105857. PubMed ID: 35803048 [Abstract] [Full Text] [Related]
13. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome. Kuppens RJ, Diène G, Bakker NE, Molinas C, Faye S, Nicolino M, Bernoux D, Delhanty PJ, van der Lely AJ, Allas S, Julien M, Delale T, Tauber M, Hokken-Koelega AC. Endocrine; 2015 Dec 23; 50(3):633-42. PubMed ID: 25989955 [Abstract] [Full Text] [Related]
14. Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial. Hollander E, Levine KG, Ferretti CJ, Freeman K, Doernberg E, Desilva N, Taylor BP. J Psychiatr Res; 2021 May 23; 137():643-651. PubMed ID: 33190843 [Abstract] [Full Text] [Related]
15. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. Goldstone AP, Holland AJ, Butler JV, Whittington JE. Int J Obes (Lond); 2012 Dec 23; 36(12):1564-70. PubMed ID: 22270375 [Abstract] [Full Text] [Related]
16. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome. Bravo GL, Poje AB, Perissinotti I, Marcondes BF, Villamar MF, Manzardo AM, Luque L, LePage JF, Stafford D, Fregni F, Butler MG. Am J Med Genet B Neuropsychiatr Genet; 2016 Mar 23; 171B(2):266-75. PubMed ID: 26590516 [Abstract] [Full Text] [Related]
17. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review. Tan Q, Orsso CE, Deehan EC, Triador L, Field CJ, Tun HM, Han JC, Müller TD, Haqq AM. Obes Rev; 2020 May 23; 21(5):e12992. PubMed ID: 31889409 [Abstract] [Full Text] [Related]
18. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial. Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan Lal TR, Abdul-Latif HD, Haqq AM, Obrynba KS, Torchen LC, Vidmar AP, Viskochil DH, Chanoine JP, Lam CKL, Pierce MJ, Williams LL, Bird LM, Butler MG, Jensen DE, Myers SE, Oatman OJ, Baskaran C, Chalmers LJ, Fu C, Alos N, McLean SD, Shah A, Whitman BY, Blumenstein BA, Leonard SF, Ernest JP, Cormier JW, Cotter SP, Ryman DC. J Clin Endocrinol Metab; 2023 Jun 16; 108(7):1696-1708. PubMed ID: 36633570 [Abstract] [Full Text] [Related]
19. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: A case-control study. Wieting J, Jahn K, Eberlein CK, Bleich S, Frieling H, Deest M. Behav Brain Res; 2023 Jul 26; 450():114494. PubMed ID: 37182741 [Abstract] [Full Text] [Related]
20. Higher plasma orexin a levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls. Manzardo AM, Johnson L, Miller JL, Driscoll DJ, Butler MG. Am J Med Genet A; 2016 Sep 26; 170(9):2328-33. PubMed ID: 27518917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]